» Articles » PMID: 26433073

MicroRNA Regulation of F-box Proteins and Its Role in Cancer

Overview
Specialty Oncology
Date 2015 Oct 4
PMID 26433073
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are small endogenous non-coding RNAs, which play critical roles in cancer development by suppressing gene expression at the post-transcriptional level. In general, oncogenic miRNAs are upregulated in cancer, while miRNAs that act as tumor suppressors are downregulated, leading to decreased expression of tumor suppressors and upregulated oncogene expression, respectively. F-box proteins function as the substrate-recognition components of the SKP1-CUL1-F-box (SCF)-ubiquitin ligase complex for the degradation of their protein targets by the ubiquitin-proteasome system. Therefore F-box proteins and miRNAs both negatively regulate target gene expression post-transcriptionally. Since each miRNA is capable of fine-tuning the expression of multiple target genes, multiple F-box proteins may be suppressed by the same miRNA. Meanwhile, one F-box proteins could be regulated by several miRNAs in different cancer types. In this review, we will focus on miRNA-mediated downregulation of various F-box proteins, the resulting stabilization of F-box protein substrates and the impact of these processes on human malignancies. We provide insight into how the miRNA: F-box protein axis may regulate cancer progression and metastasis. We also consider the broader role of F-box proteins in the regulation of pathways that are independent of the ubiquitin ligase complex and how that impacts on oncogenesis. The area of miRNAs and the F-box proteins that they regulate in cancer is an emerging field and will inform new strategies in cancer treatment.

Citing Articles

FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies.

Wang W, Jiang K, Liu X, Li J, Zhou W, Wang C Front Pharmacol. 2023; 14:1278056.

PMID: 38027013 PMC: 10680170. DOI: 10.3389/fphar.2023.1278056.


Integrated analysis of mRNA and microRNA expression profiles in hepatopancreas of under acute exposure to MC-LR.

Zhang D, Huang L, Jia Y, Zhang S, Bi X, Dai W Front Genet. 2023; 14:1088191.

PMID: 36741320 PMC: 9892846. DOI: 10.3389/fgene.2023.1088191.


Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-α expression in hydroquinone-treated leukemia cells.

Wang L, Lee Y, Chiou J, Chen Y, Chang L Cell Biol Toxicol. 2022; 39(5):2207-2225.

PMID: 35302183 DOI: 10.1007/s10565-022-09705-5.


Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm.

Chen S, Zhang E, Jiang L, Wang T, Guo T, Gao F Front Immunol. 2022; 13:798471.

PMID: 35197975 PMC: 8860306. DOI: 10.3389/fimmu.2022.798471.


Comprehensive Analysis of lncRNA and miRNA Regulatory Network Reveals Potential Prognostic Non-coding RNA Involved in Breast Cancer Progression.

Gao S, Lu X, Ma J, Zhou Q, Tang R, Fu Z Front Genet. 2021; 12:621809.

PMID: 34220926 PMC: 8253500. DOI: 10.3389/fgene.2021.621809.


References
1.
Maser R, Choudhury B, Campbell P, Feng B, Wong K, Protopopov A . Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature. 2007; 447(7147):966-71. PMC: 2714968. DOI: 10.1038/nature05886. View

2.
Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A . FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 2007; 67(19):9006-12. DOI: 10.1158/0008-5472.CAN-07-1320. View

3.
Umanskaya K, Radke S, Chander H, Monardo R, Xu X, Pan Z . Skp2B stimulates mammary gland development by inhibiting REA, the repressor of the estrogen receptor. Mol Cell Biol. 2007; 27(21):7615-22. PMC: 2169057. DOI: 10.1128/MCB.01239-07. View

4.
Frescas D, Guardavaccaro D, Bassermann F, Koyama-Nasu R, Pagano M . JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature. 2007; 450(7167):309-13. DOI: 10.1038/nature06255. View

5.
Onoyama I, Tsunematsu R, Matsumoto A, Kimura T, Moreno de Alboran I, Nakayama K . Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med. 2007; 204(12):2875-88. PMC: 2118521. DOI: 10.1084/jem.20062299. View